Meaningful use of speech scale: application to orally educated hearing-impaired children

This paper discusses a study to determine whether the use of meaningful speech in everyday situations is independent of a cochlear implant.

Evaluation of the SPICE auditory training curriculum

This study evaluates the progress of children with cochlear implants on the Speech Perception Instructional Curriculum and Evaluation (SPICE) auditory training protocol.

The effects of group-based psychosocial therapy on conversational fluency and communication handicap

This paper studies whether a combination of group rehabilitation in conjunction with psychosocial therapy enhances conversational fluency and diminishes communication handicap in cochlear implant recipients.

The relation between intelligibility and the acoustic characteristics of deaf speech: An acoustic analysis of the vowels /i/ and /aw/, and nasals

This paper discusses a study that examined acoustic measures and the relationship to speech intelligibility of children with cochlear implants.

Who am I?

This paper examines the self-image and satisfaction of cochlear implant users.

The effect of pre-implant puretone thresholds on post-implant speech perception ability in children

This paper studies the effect of residual hearing on post-implant speech perception in children with cochlear implants. The effect of pre-implant auditory experience and the effect of neuronal survival in the implanted ear were investigated.

Evaluating lexically controlled word lists for open set speech perception testing in profoundly hearing impaired children

This paper evaluates speech perception testing in pediatric cochlear implant users. Using pre-recorded stimulus presentation, the author replicated an earlier experiment comparing the Lexical Neighborhood List (LNT) test to the Phonetically Balanced Kindergarten (PB-K) test in estimating speech perception abilities in hearing impaired children.

Marginal cell density in young and old CBA/J and CBA/CAJ mice

The goal of the present study was to compare aging characteristics of the cochlear lateral wall in inbred mouse strains (CBA/J and CBA/CaJ) having very different endocochlear potential (EP)-versus-age profiles to see which anatomic differences might predict their EP differences.

Optimal dose of Kanamycin for protection from noise induced hearing loss

Young CBA/J mice were injected with kanamycin under varying schedules then exposed to noise in order to determine the boundary conditions for cochlear protection against noise.

Perceptual validation of an acoustic metric for measuring vowel production by deaf children

This paper discusses a study to validate the metric developed in the Geers and Moog Cochlear Implant Study at CID to measure the speech production of hearing impaired children.

Pediatric conversion to the HiResolution processing strategy: 6 case studies

This paper presents a study documenting the general trends in the programming techniques, aided behavioral thresholds, speech perception abilities, and overall behavior when converting children into processing strategy called HiResolution (HiRes), used with the Advanced Bionics Clarion II Cochlear Implant System.

Anatomic correlates of strial presbycusis in recombinant inbred mouse strains

This project attempts to identify anatomic features that predict the range of the ‘normal’ endocochlear potential in young inbred mice. Cochlear lateral wall histologic metrics were compared in recombinant inbred (RI) mouse strains formed from BALB/c and C57BL/6 mice.

Optimal protection of stabilised dry live bacteria from bile toxicity in oral dosage forms by bile acid adsorbent resins

We previously found that dried live bacteria of a vaccine strain can be temporarily sensitive to bile acids and suggested that Bile Adsorbing Resins (BAR) can be used in oral vaccine tablets to protect dried bacteria from intestinal bile. Here, we report a quantitative analysis of the ability of BAR to exclude the dye bromophenol blue from penetrating into matrix tablets and also sections of hard capsule shells. Based on this quantitative analysis, we made a fully optimised formulation, comprising 25% w/w of cholestyramine in Vcaps™ HPMC capsules. This gave effectively 100% protection of viability from 4% bile, with 4200-fold more live bacteria recovered from this formulation compared to unprotected dry bacteria. From the image analysis, we found that the filler material or compaction force used had no measurable effect on dye exclusion but did affect the rate of tablet hydration. Increasing the mass fraction of BAR gave more exclusion of dye up to 25% w/w, after which a plateau was reached and no further dye exclusion was seen. More effective dye exclusion was seen with smaller particle sizes (i.e. cholestyramine) and when the BAR was thoroughly dried and disaggregated. Similar results were found when imaging dye penetration into capsule sections or tablets. The predictions of the dye penetration study were tested using capsules filled with dried attenuated Salmonella vaccine plus different BAR types, and the expected protection from bile was found, validating the imaging study. Surprisingly, depending on the capsule shell material, some protection was given by the capsule alone without adding BAR, with Vcaps™ HPMC capsules providing up to 174-fold protection against 1% bile; faster releasing Vcaps Plus™ HPMC capsules and Coni Snap™ gelatin capsules gave less protection.

Protection of live bacteria from bile acid toxicity using bile acid adsorbing resins

We previously demonstrated that a dry, room temperature stable formulation of a live bacterial vaccine was highly susceptible to bile, and suggested that this will lead to significant loss of viability of any live bacterial formulation released into the intestine using an enteric coating or capsule. We found that bile and acid tolerance is very rapidly recovered after rehydration with buffer or water, raising the possibility that rehydration in the absence of bile prior to release into the intestine might solve the problem of bile toxicity to dried cells. We describe here a novel formulation that combines extensively studied bile acid adsorbent resins with the dried bacteria, to temporarily adsorb bile acids and allow rehydration and recovery of bile resistance of bacteria in the intestine before release. Tablets containing the bile acid adsorbent cholestyramine release 250-fold more live bacteria when dissolved in a bile solution, compared to control tablets without cholestyramine or with a control resin that does not bind bile acids. We propose that a simple enteric coated oral dosage form containing bile acid adsorbent resins will allow improved live bacterial delivery to the intestine via the oral route, a major step towards room temperature stable, easily administered and distributed vaccine pills and other bacterial therapeutics

Incorporation of cis-9,trans-11 or trans-10,cis-12 conjugated linoleic acid into plasma and cellular lipids in healthy men

This study investigated the incorporation of cis-9,trans-11 conjugated linoleic acid (c9,t11 CLA) and trans-10,cis-12-CLA (t10,c12 CLA) into plasma and peripheral blood mononuclear cell (PBMC) lipids when consumed as supplements highly enriched in these isomers. Healthy men (n = 49, age 31 +/- 8 years) consumed one, two, and four capsules containing similar to600 mg of either c9,t11 CIA or t10,c12 CLA per capsule for sequential 8 week periods followed by a 6 week washout before consuming the alternative isomer. Both isomers were incorporated in a dosedependent manner into plasma phosphatidylcholine (PC) (c9,t11 CLA r = 0.779, t10,c12 CLA r = 0.738; P < 0.0001) and cholesteryl ester (CE) (c9,t11 CLA r = 0.706, t10,c12 CLA r = 0.788; P < 0.0001). Only t10,c12 CLA was enriched in plasma nonesterified fatty acids. Both c9,t11 CIA and t10,c12 CLA were incorporated linearly into PBMC total lipids (r = 0.285 and r = 0.273, respectively; P < 0.0005). The highest concentrations of c9,t11 CLA and t10,c12 CLA in PBMC lipids were 3- to 4-fold lower than those in plasma PC and CE. These data suggest that the level of intake is a major determinant of plasma and PBMC CLA content, although PBMCs appear to incorporate both CLA isomers less readily.